Advances in Imaging Enhance Diagnostic Confidence in Giant Cell Arteritis

Recent insights suggest that incorporating imaging techniques can significantly improve the diagnostic precision and confidence among clinicians treating giant cell arteritis (GCA). At the Congress of Clinical Rheumatology East, Kenneth J. Warrington, MD, from the Mayo Clinic, highlighted these advancements, emphasizing the evolving nature of diagnosis and management in the context of GCA with the integration of advanced imaging.

According to Dr. Warrington, early and accurate diagnosis of GCA requires a menu of imaging options, each with its specific clinical utility. Temporal artery ultrasound, although useful, demands technical skill and may complicate diagnosis in patients with atherosclerosis due to potentially erroneous findings. Alongside, MRI with vessel wall imaging is gaining traction for its specificity and sensitivity in detecting arterial inflammation, despite its limited availability in some centers.

Other imaging modalities, such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA), serve particular roles in visualizing vascular changes. CTA can reveal vascular thickening, while MRA is adept at detecting edema and inflammation. Meanwhile, F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT is valuable for patients with complex cases, such as those presenting with fever or inflammation of unknown origin, or where malignancy is suspected.

The choice between using biopsy or ultrasound remains influenced by regional guidelines. While the American College of Rheumatology endorses biopsy, European recommendations lean towards ultrasound. Dr. Warrington advises clinicians to adhere to local guidelines and tailor their approach based on individual patient needs.

Overall, the integration of comprehensive imaging techniques alongside temporal artery biopsy is underscored as a critical approach in achieving a precise diagnosis and understanding of GCA. This strategic combination not only enhances clarity but also supports a more informed management plan for patients.

Dr. Warrington's insights reinforce the essential role of advanced imaging in rheumatology, advocating for its considered application in practice to optimize diagnostic outcomes for GCA.